Methods and compositions for tissue regeneration
First Claim
1. A method of treating a wound comprising applying a composition to a wound site on a patient in need of wound treatment, wherein the composition comprises mitotically inactive allogeneic cells that secrete one or more biologically active molecules selected from the group consisting of GM-CSF, VEGF, KGF, bFGF, TGFβ
- , angiopoietin, EGF, IL-Iβ
, IL-6, IL-8, TGFα
, and TNFα
, and wherein the cells are keratinocytes or fibroblasts, or mixtures thereof.
6 Assignments
0 Petitions
Accused Products
Abstract
Disclosed is a method of treating a wound comprising applying a composition to a wound site on a patient in need of wound treatment, wherein the composition comprises mitotically inactive allogeneic cells that secrete one or more biologically active molecules selected from the group consisting of GM-CSF, VEGF, KGF, bFGF, TGFβ, angiopoietin, EGF, IL-Iβ, IL-6 IL-8, TGFα, and TNFα, and wherein the cells are keratinocytes or fibroblasts, or mixtures thereof.
32 Citations
17 Claims
-
1. A method of treating a wound comprising applying a composition to a wound site on a patient in need of wound treatment, wherein the composition comprises mitotically inactive allogeneic cells that secrete one or more biologically active molecules selected from the group consisting of GM-CSF, VEGF, KGF, bFGF, TGFβ
- , angiopoietin, EGF, IL-Iβ
, IL-6, IL-8, TGFα
, and TNFα
, and wherein the cells are keratinocytes or fibroblasts, or mixtures thereof. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)
- , angiopoietin, EGF, IL-Iβ
Specification